Dana-Farberications: The Knight's Move That Shook Harvard
Season 1 | Episode 15
33m | Sep 14, 2026How a Science Sleuth Exposed a $15M Fraud?
What happens when the generals in the war on cancer are caught stretching, splicing, and duplicating their data?
In this investigative episode, we dive into the heart of the American medical establishment to examine the Dana-Farber Cancer Institute data manipulation scandal. Dana-Farber—a crown jewel of Harvard Medical School generating $3.4 billion in annual revenue—was rocked when dozens of studies authored by its top leadership were flagged for blatant image alterations.
Inside this episode:
- The Titans of Oncology:** Meet the elite researchers at the center of the storm—CEO Dr. Laurie Glimcher, COO Dr. William Hahn, multiple myeloma pioneer Dr. Kenneth Anderson, and early-interception specialist Dr. Irene Ghobrial.
- The Sleuth with an Eagle Eye:** How Dr. Sholto David, an independent biologist working out of Wales, used ImageTwin and PubPeer to uncover patterns of manipulated Western blots and duplicated mice across dozens of high-profile papers.
- The Internal Meltdown:** Dana-Farber’s damage-control effort, the defense of "no intent to deceive," and the conflict of interest surrounding Research Integrity Officer Dr. Barrett Rollins.
- The $15 Million Whistleblower Lawsuit:** How David weaponized the Civil War-era False Claims Act, triggering a swift Department of Justice investigation and walking away with a historic $2.625 million relator payout.
- Too Big to Fail" in Biomedicine:** Why, despite retractions and a massive federal settlement, senior academic leaders remain shielded by endowed chairs, NIH study-section politics, and lucrative clinical networks.
Can the public still trust preliminary science when billions in federal grants and drug therapies are on the line?
Listen now, and always question the data.

THE ARTIFACT: True Stories of Fraud, Ego, and the Lies We Call Fact
Loading...